Elevated platelet-to-lymphocyte corresponds with poor outcome in patients with advanced cancer receiving anti-PD-1 therapy

导出原文传递

翻译打印收藏纠错

作者： Qi, Yalong ^[1] ; Liao, Daixiang ^[2] ; Fu, Xiaomin ; Gao, Quanli ; Zhang, Yong

作者单位： Beijing Mentougou Dist Hosp, Dept Oncol, 10 He Tan Qiao East Rd, Beijing 102300, Peoples R China ^[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Biol & Immunotherapy, 127 Dong Ming Rd, Zhengzhou 450008 ^[2]

关键词 Platelet-to-lymphocyte ratio PD-1 inhibitor Biomarker Prognosis

发布时间 2019-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

International immunopharmacology

2019年74卷

Article 105707-Article 105707页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Elevated platelet-to-lymphocyte corresponds with poor outcome in patients with advanced cancer receiving anti-PD-1 therapy

International immunopharmacology

相似文献

International immunopharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Elevated platelet-to-lymphocyte corresponds with poor outcome in patients with advanced cancer receiving anti-PD-1 therapy

International immunopharmacology

相似文献

International immunopharmacology

相关期刊

检索历史清除